Foster Dykema Cabot & Co. Inc. MA purchased a new stake in Waters Co. (NYSE:WAT – Get Rating) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 340 shares of the medical instruments supplier's stock, valued at approximately $113,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Ellevest Inc. boosted its stake in shares of Waters by 144.4% in the 1st quarter. Ellevest Inc. now owns 88 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 52 shares during the last quarter. Kenfarb & CO. bought a new stake in shares of Waters in the 4th quarter valued at $48,000. Tyler Stone Wealth Management bought a new stake in shares of Waters in the 4th quarter valued at $56,000. Allworth Financial LP boosted its stake in shares of Waters by 48.4% in the 2nd quarter. Allworth Financial LP now owns 187 shares of the medical instruments supplier's stock valued at $62,000 after purchasing an additional 61 shares during the last quarter. Finally, Quent Capital LLC bought a new stake in shares of Waters in the 4th quarter valued at $75,000. 88.80% of the stock is currently owned by institutional investors and hedge funds.
Get
Waters alerts:
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on WAT shares. Barclays reduced their price objective on shares of Waters from $375.00 to $345.00 and set an "overweight" rating on the stock in a research note on Monday, September 12th. Cowen increased their target price on shares of Waters to $378.00 in a research note on Tuesday, August 9th. Credit Suisse Group initiated coverage on shares of Waters in a research note on Wednesday, August 24th. They set a "neutral" rating and a $345.00 target price on the stock. Robert W. Baird increased their target price on shares of Waters from $340.00 to $348.00 in a research note on Wednesday, August 3rd. Finally, UBS Group increased their target price on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a research note on Thursday, August 4th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $348.25.
Waters Stock Up 0.1 %
Shares of Waters stock traded up $0.38 during trading hours on Friday, reaching $275.50. The company's stock had a trading volume of 304,739 shares, compared to its average volume of 376,943. Waters Co. has a one year low of $270.36 and a one year high of $399.81. The company has a market capitalization of $16.50 billion, a P/E ratio of 24.04, a P/E/G ratio of 2.98 and a beta of 0.87. The stock's fifty day simple moving average is $319.36 and its two-hundred day simple moving average is $320.70. The company has a debt-to-equity ratio of 3.66, a quick ratio of 1.55 and a current ratio of 2.10.
Waters (NYSE:WAT – Get Rating) last released its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The firm had revenue of $714.30 million for the quarter, compared to analyst estimates of $706.77 million. During the same period last year, the firm earned $2.60 earnings per share. The business's quarterly revenue was up 4.8% compared to the same quarter last year. On average, research analysts forecast that Waters Co. will post 12 earnings per share for the current year.
About Waters
(Get Rating)
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Get a free copy of the StockNews.com research report on Waters (WAT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
